Primary Sjögren's syndrome. Clinical and laboratory markers of disease activityOXHOLM, P.Seminars in arthritis and rheumatism. 1992, Vol 22, Num 2, pp 114-126, issn 0049-0172Article

Standardized assessment of disease status in patients with primary Sjögren's syndrome : The foundation for creating criteria for disease activity and damage?OXHOLM, P; ASMUSSEN, K.Medical hypotheses. 1998, Vol 50, Num 6, pp 483-492, issn 0306-9877Article

Impaired release of natural killer cytotoxic factor in patients with primary Sjögren's syndromePEDERSEN, B. K; OXHOLM, P.Clinical and experimental immunology (Print). 1988, Vol 72, Num 2, pp 299-302, issn 0009-9104Article

PULMONARY FUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITISOXHOLM P; MADSEN EB; MANTHORPE R et al.1982; SCAND. J. RHEUMATOL.; ISSN 0300-9742; SWE; DA. 1982; VOL. 11; NO 2; PP. 109-112; BIBL. 12 REF.Article

Platelet-associated immunoglobulins in patients with primary Sjögren's syndromeOXHOLM, P; WINTHER, K; TAANING, E et al.Scandinavian journal of rheumatology. 1991, Vol 20, Num 1, pp 16-22, issn 0300-9742, 7 p.Article

Expression of interleukin-6-like molecules and tumour necrosis factor after topical treatment of psoriasis with vitamin D analogue (MC 903)OXHOLM, A; OXHOLM, P; STABERG, B et al.Acta dermato-venereologica. 1989, Vol 69, Num 5, pp 385-390, issn 0001-5555Article

Characterization of the in vivo and in vitro effects of indomethacin on human natural killer cell activityPEDERSEN, B. K; OXHOLM, P; KLARLUND, K et al.Allergy (Copenhagen). 1986, Vol 41, Num 7, pp 532-536, issn 0105-4538Article

PULMONARY FUNCTION IN PATIENTS WITH PRIMARY SJOEGREN'S SYNDROMEOXHOLM P; BUNDGAARD A; BIRK MADSEN E et al.1982; RHEUMATOL. INT.; ISSN 0172-8172; DEU; DA. 1982; VOL. 2; NO 4; PP. 179-181; BIBL. 9 REF.Article

Rational drug therapy recommendations for the treatment of patients with Sjögren's syndromeOXHOLM, P; PRAUSE, J. U; SCHIØDT, M et al.Drugs (Basel). 1998, Vol 56, Num 3, pp 345-353, issn 0012-6667Article

Cytokine expression in labial salivary glands from patients with primary Sjögren's syndromeOXHOLM, P; DANIELS, T. E; BENDTZEN, K et al.Autoimmunity (Print). 1992, Vol 12, Num 3, pp 185-191, issn 0891-6934Article

Immunohistological detection of interleukin I-like molecules and tumour necrosis factor in human epidermis before and after UVB-irradiation in vivoOXHOLM, A; OXHOLM, P; STABERG, B et al.British journal of dermatology (1951). 1988, Vol 118, Num 3, pp 369-376, issn 0007-0963Article

Immunohistochemical characterization of intraepidermal in vivo IgG deposits in patients with primary Sjögren's syndromeOXHOLM, P; OXHOLM, A; PRAUSE, J. U et al.Acta pathologica, microbiologica et immunologica Scandinavica. Section A. Pathology. 1987, Vol 95, Num 5, pp 239-244, issn 0108-0164Article

Keratinocyte-expression of interleukin-6 but not of tumour necrosis factor-alpha is increased in the allergic and the irritant patch test reactionOXHOLM, A; OXHOLM, P; AVNSTORP, C et al.Acta dermato-venereologica. 1991, Vol 71, Num 2, pp 93-98, issn 0001-5555, 6 p.Article

Langerhans cells in labial minor salivary glands in primary Sjögren's syndromeOXHOLM, P; MANTHORPE, R; OXHOLM, A et al.Acta pathologica, microbiologica et immunologica Scandinavica. Section A. Pathology. 1985, Vol 93, Num 2, pp 105-107, issn 0108-0164Article

Lack of evidence for human lymphokines with thrombocyte aggregating activity. An in vitro studyOXHOLM, P; WINTHER, K; BENDTZEN, K et al.Allergy (Copenhagen). 1984, Vol 39, Num 8, pp 618-621, issn 0105-4538Article

Sialochemistry in Sjögren's syndrome: a reviewTHORN, J. J; PRAUSE, J. U; OXHOLM, P et al.Journal of oral pathology. 1989, Vol 18, Num 8, pp 457-468, issn 0300-9777Article

Effect of auranofin on human platelet aggregation, release of serotonin, and cyclic-AMP formationWINTHER, K; OXHOLM, P; SENGELOV, H et al.Inflammation. 1988, Vol 12, Num 1, pp 107-112, issn 0360-3997Article

Immunohistological skin investigations in patients with the acquired immune deficiency syndromeOXHOLM, P; HELWEG-LARSEN, S; PERMIN, H et al.Acta pathologica, microbiologica et immunologica Scandinavica. Section A. Pathology. 1986, Vol 94, Num 2, pp 113-116, issn 0108-0164Article

Platelet function in patients with primary Sjögren's syndromeOXHOLM, P; WINTHER, K; MANTHORPE, R et al.Acta medica Scandinavica. 1986, Vol 219, Num 1, pp 85-90, issn 0001-6101Article

Epidermal Langerhans cells in patients with primary Sjögren's syndromeOXHOLM, P; OXHOLM, A; MANTHORPE, R et al.Allergy (Copenhagen). 1986, Vol 41, Num 6, pp 429-434, issn 0105-4538Article

SYSTEMIC LUPUS ERYTHEMATOSUS: A ZOONOSIS.OXHOLM P; BENDIXEN G; FLAGSTAD A et al.1979; SCAND. J. RHEUMATOL.; SWE; DA. 1979; VOL. 8; NO 4; PP. 222-224; BIBL. 12 REF.Article

Soluble interleukin-2 receptors in serum from patients with primary Sjögren's syndromeDIAMANT, M; TVEDE, N; PRAUSE, J. U et al.Scandinavian journal of rheumatology. 1991, Vol 20, Num 5, pp 370-372, issn 0300-9742Article

Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndromePEDERSEN, B. K; OXHOLM, P; MANTHORPE, R et al.Clinical and experimental immunology (Print). 1986, Vol 63, Num 1, pp 1-7, issn 0009-9104Article

Patients with primary Sjögren's syndrome treated for two months with evening primrose oilOXHOLM, P; MANTHORPE, R; PRAUSE, J. U et al.Scandinavian journal of rheumatology. 1986, Vol 15, Num 2, pp 103-108, issn 0300-9742Article

Abnormal essential fatty acid metabolism in Darier's diseaseOXHOLM, A; OXHOLM, P; DA CUNHA BANG, F et al.Archives of dermatology (1960). 1990, Vol 126, Num 10, pp 1308-1311, issn 0003-987X, 4 p.Article